Oct 12, 2026 10:43AM
Oct 12, 2026 09:35AM
Oct 12, 2026 08:00AM
Oct 12, 2026 08:00AM
Sep 29, 2026 06:47AM
Sep 28, 2026 02:02PM
Sep 28, 2026 08:00AM Mirum's brelovitug meets Phase 3 primary endpoint in hepatitis delta trial
Sep 28, 2026 08:00AM
Sep 25, 2026 07:00PM
Sep 25, 2026 07:00PM
Sep 14, 2026 04:01PM
Aug 20, 2026 06:53AM
Aug 11, 2026 04:01PM
Aug 5, 2026 04:01PM Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Jul 29, 2026 04:01PM
Jul 13, 2026 04:01PM
Jun 14, 2026 04:35PM
Jun 14, 2026 04:35PM
Jun 11, 2026 04:01PM
Jun 4, 2026 08:06AM
Jun 4, 2026 08:05AM Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
Jun 1, 2026 02:53AM
May 30, 2026 12:00PM
May 21, 2026 08:05AM
May 19, 2026 05:33AM
May 14, 2026 04:01PM
May 12, 2026 11:56PM
May 12, 2026 11:56PM Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes
May 12, 2026 04:01PM
May 12, 2026 04:01PM
May 12, 2026 08:00AM
May 6, 2026 04:01PM
May 4, 2026 08:01AM
May 4, 2026 08:00AM
Apr 27, 2026 08:00AM MIRUM meets primary endpoint in hepatitis delta drug trial
Apr 27, 2026 08:00AM
Mar 16, 2026 08:00AM
Mar 16, 2026 08:00AM
Mar 5, 2026 08:00AM
Feb 26, 2026 04:49AM
Feb 25, 2026 04:01PM
Feb 5, 2026 08:52AM Mirum receives Health Canada approval for LIVMARLI tablet formulation
Feb 5, 2026 08:51AM
Feb 5, 2026 08:01AM
Feb 5, 2026 08:00AM
Jan 26, 2026 08:00AM
Jan 26, 2026 08:00AM
Jan 12, 2026 08:31AM
Jan 12, 2026 08:30AM Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum
Dec 19, 2025 04:08PM

334,456 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All